Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits

University of British Columbia2 sites in 1 country460 target enrollmentMay 20, 2022

ConditionsDecision Making, Shared Pregnancy Preterm Birth

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Decision Making, Shared
Sponsor: University of British Columbia
Enrollment: 460
Locations: 2
Primary Endpoint: The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Registry

clinicaltrials.gov

Start Date

May 20, 2022

End Date

February 1, 2024

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

University of British Columbia

Responsible Party

Principal Investigator

Jessica Liauw

Clinical Assistant Professor

University of British Columbia

Eligibility Criteria

Inclusion Criteria

•Age 18 year or older.
•Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
•Speaks English.
•Agrees to participate in the questionnaire during their first week post-partum.
•Delivered at one of the six participating obstetrical hospitals.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

The change in frequency of clinical counselling about late preterm antenatal corticosteroids.

Time Frame: up to 8 months following implementation of the intervention.

The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention.

Secondary Outcomes

The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.(up to 8 months following implementation of the intervention.)